aluates Reports

$ 0.0

Automative

Global Plague Therapeutics Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-7Q13792

Global Plague Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Plague Therapeutics Market Research Report 2025

Code: QYRE-Auto-7Q13792

Report

June 2025

Pages:109

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CordenPharma

Cipher Pharmaceuticals

Pfizer Inc

Bayer HealthCare

Eli Lilly

Achaogen Inc

Aurobindo Pharma

GlaxoSmithKline PLC

Bristol–Myers Squibb

Aspen Pharmacare

Biocon Ltd.

Astellas Pharma

Melinta Therapeutics

Basilea Pharmaceutica

Allergan plc

Abbott

Astrazeneca plc

AmpliPhi Biosciences

Actelion Pharmaceuticals

Chiesi Farmaceutici

Exoxemis

Merck

DynPort Vaccine Company LLC

Plague Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Plague Therapeutics Market

The global market for Plague Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Plague Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plague Therapeutics.

The Plague Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plague Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Plague Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Plague Therapeutics Market Report

Report Metric	Details
Report Name	Plague Therapeutics Market
CAGR	5%
Segment by Type	Vaccine Drugs
Segment by Application	Hospital Pharmacies Retail Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CordenPharma, Cipher Pharmaceuticals, Pfizer, Bayer HealthCare, Eli Lilly, Achaogen, Aurobindo Pharma, GlaxoSmithKline, Bristol-Myers Squibb, Aspen Pharmacare, Biocon, Astellas Pharma, Melinta Therapeutics, Basilea Pharmaceutica, Allergan, Abbott, AstraZeneca, AmpliPhi Biosciences, Actelion Pharmaceuticals, Chiesi Farmaceutici, Exoxemis, Merck, DynPort Vaccine Company LLC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plague Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Plague Therapeutics Market report?

Ans: The main players in the Plague Therapeutics Market are CordenPharma, Cipher Pharmaceuticals, Pfizer, Bayer HealthCare, Eli Lilly, Achaogen, Aurobindo Pharma, GlaxoSmithKline, Bristol-Myers Squibb, Aspen Pharmacare, Biocon, Astellas Pharma, Melinta Therapeutics, Basilea Pharmaceutica, Allergan, Abbott, AstraZeneca, AmpliPhi Biosciences, Actelion Pharmaceuticals, Chiesi Farmaceutici, Exoxemis, Merck, DynPort Vaccine Company LLC

What are the Application segmentation covered in the Plague Therapeutics Market report?

Ans: The Applications covered in the Plague Therapeutics Market report are Hospital Pharmacies, Retail Pharmacies, Others

What are the Type segmentation covered in the Plague Therapeutics Market report?

Ans: The Types covered in the Plague Therapeutics Market report are Vaccine, Drugs

Recommended Reports

Infectious Disease Therapy

Pharmaceutical Therapeutics

Drug & Vaccine Landscape

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Plague Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Vaccine

1.2.3 Drugs

1.3 Market by Application

1.3.1 Global Plague Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Plague Therapeutics Market Perspective (2020-2031)

2.2 Global Plague Therapeutics Growth Trends by Region

2.2.1 Global Plague Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Plague Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Plague Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Plague Therapeutics Market Dynamics

2.3.1 Plague Therapeutics Industry Trends

2.3.2 Plague Therapeutics Market Drivers

2.3.3 Plague Therapeutics Market Challenges

2.3.4 Plague Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Plague Therapeutics Players by Revenue

3.1.1 Global Top Plague Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Plague Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Plague Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Plague Therapeutics Revenue

3.4 Global Plague Therapeutics Market Concentration Ratio

3.4.1 Global Plague Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Plague Therapeutics Revenue in 2024

3.5 Global Key Players of Plague Therapeutics Head office and Area Served

3.6 Global Key Players of Plague Therapeutics, Product and Application

3.7 Global Key Players of Plague Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Plague Therapeutics Breakdown Data by Type

4.1 Global Plague Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Plague Therapeutics Forecasted Market Size by Type (2026-2031)

5 Plague Therapeutics Breakdown Data by Application

5.1 Global Plague Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Plague Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Plague Therapeutics Market Size (2020-2031)

6.2 North America Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Plague Therapeutics Market Size by Country (2020-2025)

6.4 North America Plague Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Plague Therapeutics Market Size (2020-2031)

7.2 Europe Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Plague Therapeutics Market Size by Country (2020-2025)

7.4 Europe Plague Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Plague Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Plague Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Plague Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Plague Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Plague Therapeutics Market Size (2020-2031)

9.2 Latin America Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Plague Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Plague Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Plague Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Plague Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Plague Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Plague Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 CordenPharma

11.1.1 CordenPharma Company Details

11.1.2 CordenPharma Business Overview

11.1.3 CordenPharma Plague Therapeutics Introduction

11.1.4 CordenPharma Revenue in Plague Therapeutics Business (2020-2025)

11.1.5 CordenPharma Recent Development

11.2 Cipher Pharmaceuticals

11.2.1 Cipher Pharmaceuticals Company Details

11.2.2 Cipher Pharmaceuticals Business Overview

11.2.3 Cipher Pharmaceuticals Plague Therapeutics Introduction

11.2.4 Cipher Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025)

11.2.5 Cipher Pharmaceuticals Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Plague Therapeutics Introduction

11.3.4 Pfizer Revenue in Plague Therapeutics Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Bayer HealthCare

11.4.1 Bayer HealthCare Company Details

11.4.2 Bayer HealthCare Business Overview

11.4.3 Bayer HealthCare Plague Therapeutics Introduction

11.4.4 Bayer HealthCare Revenue in Plague Therapeutics Business (2020-2025)

11.4.5 Bayer HealthCare Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Details

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Plague Therapeutics Introduction

11.5.4 Eli Lilly Revenue in Plague Therapeutics Business (2020-2025)

11.5.5 Eli Lilly Recent Development

11.6 Achaogen

11.6.1 Achaogen Company Details

11.6.2 Achaogen Business Overview

11.6.3 Achaogen Plague Therapeutics Introduction

11.6.4 Achaogen Revenue in Plague Therapeutics Business (2020-2025)

11.6.5 Achaogen Recent Development

11.7 Aurobindo Pharma

11.7.1 Aurobindo Pharma Company Details

11.7.2 Aurobindo Pharma Business Overview

11.7.3 Aurobindo Pharma Plague Therapeutics Introduction

11.7.4 Aurobindo Pharma Revenue in Plague Therapeutics Business (2020-2025)

11.7.5 Aurobindo Pharma Recent Development

11.8 GlaxoSmithKline

11.8.1 GlaxoSmithKline Company Details

11.8.2 GlaxoSmithKline Business Overview

11.8.3 GlaxoSmithKline Plague Therapeutics Introduction

11.8.4 GlaxoSmithKline Revenue in Plague Therapeutics Business (2020-2025)

11.8.5 GlaxoSmithKline Recent Development

11.9 Bristol-Myers Squibb

11.9.1 Bristol-Myers Squibb Company Details

11.9.2 Bristol-Myers Squibb Business Overview

11.9.3 Bristol-Myers Squibb Plague Therapeutics Introduction

11.9.4 Bristol-Myers Squibb Revenue in Plague Therapeutics Business (2020-2025)

11.9.5 Bristol-Myers Squibb Recent Development

11.10 Aspen Pharmacare

11.10.1 Aspen Pharmacare Company Details

11.10.2 Aspen Pharmacare Business Overview

11.10.3 Aspen Pharmacare Plague Therapeutics Introduction

11.10.4 Aspen Pharmacare Revenue in Plague Therapeutics Business (2020-2025)

11.10.5 Aspen Pharmacare Recent Development

11.11 Biocon

11.11.1 Biocon Company Details

11.11.2 Biocon Business Overview

11.11.3 Biocon Plague Therapeutics Introduction

11.11.4 Biocon Revenue in Plague Therapeutics Business (2020-2025)

11.11.5 Biocon Recent Development

11.12 Astellas Pharma

11.12.1 Astellas Pharma Company Details

11.12.2 Astellas Pharma Business Overview

11.12.3 Astellas Pharma Plague Therapeutics Introduction

11.12.4 Astellas Pharma Revenue in Plague Therapeutics Business (2020-2025)

11.12.5 Astellas Pharma Recent Development

11.13 Melinta Therapeutics

11.13.1 Melinta Therapeutics Company Details

11.13.2 Melinta Therapeutics Business Overview

11.13.3 Melinta Therapeutics Plague Therapeutics Introduction

11.13.4 Melinta Therapeutics Revenue in Plague Therapeutics Business (2020-2025)

11.13.5 Melinta Therapeutics Recent Development

11.14 Basilea Pharmaceutica

11.14.1 Basilea Pharmaceutica Company Details

11.14.2 Basilea Pharmaceutica Business Overview

11.14.3 Basilea Pharmaceutica Plague Therapeutics Introduction

11.14.4 Basilea Pharmaceutica Revenue in Plague Therapeutics Business (2020-2025)

11.14.5 Basilea Pharmaceutica Recent Development

11.15 Allergan

11.15.1 Allergan Company Details

11.15.2 Allergan Business Overview

11.15.3 Allergan Plague Therapeutics Introduction

11.15.4 Allergan Revenue in Plague Therapeutics Business (2020-2025)

11.15.5 Allergan Recent Development

11.16 Abbott

11.16.1 Abbott Company Details

11.16.2 Abbott Business Overview

11.16.3 Abbott Plague Therapeutics Introduction

11.16.4 Abbott Revenue in Plague Therapeutics Business (2020-2025)

11.16.5 Abbott Recent Development

11.17 AstraZeneca

11.17.1 AstraZeneca Company Details

11.17.2 AstraZeneca Business Overview

11.17.3 AstraZeneca Plague Therapeutics Introduction

11.17.4 AstraZeneca Revenue in Plague Therapeutics Business (2020-2025)

11.17.5 AstraZeneca Recent Development

11.18 AmpliPhi Biosciences

11.18.1 AmpliPhi Biosciences Company Details

11.18.2 AmpliPhi Biosciences Business Overview

11.18.3 AmpliPhi Biosciences Plague Therapeutics Introduction

11.18.4 AmpliPhi Biosciences Revenue in Plague Therapeutics Business (2020-2025)

11.18.5 AmpliPhi Biosciences Recent Development

11.19 Actelion Pharmaceuticals

11.19.1 Actelion Pharmaceuticals Company Details

11.19.2 Actelion Pharmaceuticals Business Overview

11.19.3 Actelion Pharmaceuticals Plague Therapeutics Introduction

11.19.4 Actelion Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025)

11.19.5 Actelion Pharmaceuticals Recent Development

11.20 Chiesi Farmaceutici

11.20.1 Chiesi Farmaceutici Company Details

11.20.2 Chiesi Farmaceutici Business Overview

11.20.3 Chiesi Farmaceutici Plague Therapeutics Introduction

11.20.4 Chiesi Farmaceutici Revenue in Plague Therapeutics Business (2020-2025)

11.20.5 Chiesi Farmaceutici Recent Development

11.21 Exoxemis

11.21.1 Exoxemis Company Details

11.21.2 Exoxemis Business Overview

11.21.3 Exoxemis Plague Therapeutics Introduction

11.21.4 Exoxemis Revenue in Plague Therapeutics Business (2020-2025)

11.21.5 Exoxemis Recent Development

11.22 Merck

11.22.1 Merck Company Details

11.22.2 Merck Business Overview

11.22.3 Merck Plague Therapeutics Introduction

11.22.4 Merck Revenue in Plague Therapeutics Business (2020-2025)

11.22.5 Merck Recent Development

11.23 DynPort Vaccine Company LLC

11.23.1 DynPort Vaccine Company LLC Company Details

11.23.2 DynPort Vaccine Company LLC Business Overview

11.23.3 DynPort Vaccine Company LLC Plague Therapeutics Introduction

11.23.4 DynPort Vaccine Company LLC Revenue in Plague Therapeutics Business (2020-2025)

11.23.5 DynPort Vaccine Company LLC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

CordenPharma

Cipher Pharmaceuticals

Pfizer Inc

Bayer HealthCare

Eli Lilly

Achaogen Inc

Aurobindo Pharma

GlaxoSmithKline PLC

Bristol–Myers Squibb

Aspen Pharmacare

Biocon Ltd.

Astellas Pharma

Melinta Therapeutics

Basilea Pharmaceutica

Allergan plc

Abbott

Astrazeneca plc

AmpliPhi Biosciences

Actelion Pharmaceuticals

Chiesi Farmaceutici

Exoxemis

Merck

DynPort Vaccine Company LLC

List of Tables

Table 1. Global Plague Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Vaccine

Table 3. Key Players of Drugs

Table 4. Global Plague Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Plague Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Plague Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Plague Therapeutics Market Share by Region (2020-2025)

Table 8. Global Plague Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Plague Therapeutics Market Share by Region (2026-2031)

Table 10. Plague Therapeutics Market Trends

Table 11. Plague Therapeutics Market Drivers

Table 12. Plague Therapeutics Market Challenges

Table 13. Plague Therapeutics Market Restraints

Table 14. Global Plague Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Plague Therapeutics Market Share by Players (2020-2025)

Table 16. Global Top Plague Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plague Therapeutics as of 2024)

Table 17. Ranking of Global Top Plague Therapeutics Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Plague Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Plague Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Plague Therapeutics, Product and Application

Table 21. Global Key Players of Plague Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Plague Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Plague Therapeutics Revenue Market Share by Type (2020-2025)

Table 25. Global Plague Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Plague Therapeutics Revenue Market Share by Type (2026-2031)

Table 27. Global Plague Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Plague Therapeutics Revenue Market Share by Application (2020-2025)

Table 29. Global Plague Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Plague Therapeutics Revenue Market Share by Application (2026-2031)

Table 31. North America Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Plague Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Plague Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Plague Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Plague Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Plague Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Plague Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. CordenPharma Company Details

Table 47. CordenPharma Business Overview

Table 48. CordenPharma Plague Therapeutics Product

Table 49. CordenPharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 50. CordenPharma Recent Development

Table 51. Cipher Pharmaceuticals Company Details

Table 52. Cipher Pharmaceuticals Business Overview

Table 53. Cipher Pharmaceuticals Plague Therapeutics Product

Table 54. Cipher Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 55. Cipher Pharmaceuticals Recent Development

Table 56. Pfizer Company Details

Table 57. Pfizer Business Overview

Table 58. Pfizer Plague Therapeutics Product

Table 59. Pfizer Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 60. Pfizer Recent Development

Table 61. Bayer HealthCare Company Details

Table 62. Bayer HealthCare Business Overview

Table 63. Bayer HealthCare Plague Therapeutics Product

Table 64. Bayer HealthCare Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 65. Bayer HealthCare Recent Development

Table 66. Eli Lilly Company Details

Table 67. Eli Lilly Business Overview

Table 68. Eli Lilly Plague Therapeutics Product

Table 69. Eli Lilly Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 70. Eli Lilly Recent Development

Table 71. Achaogen Company Details

Table 72. Achaogen Business Overview

Table 73. Achaogen Plague Therapeutics Product

Table 74. Achaogen Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 75. Achaogen Recent Development

Table 76. Aurobindo Pharma Company Details

Table 77. Aurobindo Pharma Business Overview

Table 78. Aurobindo Pharma Plague Therapeutics Product

Table 79. Aurobindo Pharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 80. Aurobindo Pharma Recent Development

Table 81. GlaxoSmithKline Company Details

Table 82. GlaxoSmithKline Business Overview

Table 83. GlaxoSmithKline Plague Therapeutics Product

Table 84. GlaxoSmithKline Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 85. GlaxoSmithKline Recent Development

Table 86. Bristol-Myers Squibb Company Details

Table 87. Bristol-Myers Squibb Business Overview

Table 88. Bristol-Myers Squibb Plague Therapeutics Product

Table 89. Bristol-Myers Squibb Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 90. Bristol-Myers Squibb Recent Development

Table 91. Aspen Pharmacare Company Details

Table 92. Aspen Pharmacare Business Overview

Table 93. Aspen Pharmacare Plague Therapeutics Product

Table 94. Aspen Pharmacare Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 95. Aspen Pharmacare Recent Development

Table 96. Biocon Company Details

Table 97. Biocon Business Overview

Table 98. Biocon Plague Therapeutics Product

Table 99. Biocon Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 100. Biocon Recent Development

Table 101. Astellas Pharma Company Details

Table 102. Astellas Pharma Business Overview

Table 103. Astellas Pharma Plague Therapeutics Product

Table 104. Astellas Pharma Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 105. Astellas Pharma Recent Development

Table 106. Melinta Therapeutics Company Details

Table 107. Melinta Therapeutics Business Overview

Table 108. Melinta Therapeutics Plague Therapeutics Product

Table 109. Melinta Therapeutics Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 110. Melinta Therapeutics Recent Development

Table 111. Basilea Pharmaceutica Company Details

Table 112. Basilea Pharmaceutica Business Overview

Table 113. Basilea Pharmaceutica Plague Therapeutics Product

Table 114. Basilea Pharmaceutica Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 115. Basilea Pharmaceutica Recent Development

Table 116. Allergan Company Details

Table 117. Allergan Business Overview

Table 118. Allergan Plague Therapeutics Product

Table 119. Allergan Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 120. Allergan Recent Development

Table 121. Abbott Company Details

Table 122. Abbott Business Overview

Table 123. Abbott Plague Therapeutics Product

Table 124. Abbott Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 125. Abbott Recent Development

Table 126. AstraZeneca Company Details

Table 127. AstraZeneca Business Overview

Table 128. AstraZeneca Plague Therapeutics Product

Table 129. AstraZeneca Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 130. AstraZeneca Recent Development

Table 131. AmpliPhi Biosciences Company Details

Table 132. AmpliPhi Biosciences Business Overview

Table 133. AmpliPhi Biosciences Plague Therapeutics Product

Table 134. AmpliPhi Biosciences Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 135. AmpliPhi Biosciences Recent Development

Table 136. Actelion Pharmaceuticals Company Details

Table 137. Actelion Pharmaceuticals Business Overview

Table 138. Actelion Pharmaceuticals Plague Therapeutics Product

Table 139. Actelion Pharmaceuticals Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 140. Actelion Pharmaceuticals Recent Development

Table 141. Chiesi Farmaceutici Company Details

Table 142. Chiesi Farmaceutici Business Overview

Table 143. Chiesi Farmaceutici Plague Therapeutics Product

Table 144. Chiesi Farmaceutici Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 145. Chiesi Farmaceutici Recent Development

Table 146. Exoxemis Company Details

Table 147. Exoxemis Business Overview

Table 148. Exoxemis Plague Therapeutics Product

Table 149. Exoxemis Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 150. Exoxemis Recent Development

Table 151. Merck Company Details

Table 152. Merck Business Overview

Table 153. Merck Plague Therapeutics Product

Table 154. Merck Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 155. Merck Recent Development

Table 156. DynPort Vaccine Company LLC Company Details

Table 157. DynPort Vaccine Company LLC Business Overview

Table 158. DynPort Vaccine Company LLC Plague Therapeutics Product

Table 159. DynPort Vaccine Company LLC Revenue in Plague Therapeutics Business (2020-2025) & (US$ Million)

Table 160. DynPort Vaccine Company LLC Recent Development

Table 161. Research Programs/Design for This Report

Table 162. Key Data Information from Secondary Sources

Table 163. Key Data Information from Primary Sources

Table 164. Authors List of This Report

List of Figures

Figure 1. Plague Therapeutics Picture

Figure 2. Global Plague Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Plague Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Vaccine Features

Figure 5. Drugs Features

Figure 6. Global Plague Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Plague Therapeutics Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacies Case Studies

Figure 9. Retail Pharmacies Case Studies

Figure 10. Others Case Studies

Figure 11. Plague Therapeutics Report Years Considered

Figure 12. Global Plague Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Plague Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Plague Therapeutics Market Share by Region: 2024 VS 2031

Figure 15. Global Plague Therapeutics Market Share by Players in 2024

Figure 16. Global Top Plague Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plague Therapeutics as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Plague Therapeutics Revenue in 2024

Figure 18. North America Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Plague Therapeutics Market Share by Country (2020-2031)

Figure 20. United States Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Plague Therapeutics Market Share by Country (2020-2031)

Figure 24. Germany Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Plague Therapeutics Market Share by Region (2020-2031)

Figure 32. China Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Plague Therapeutics Market Share by Country (2020-2031)

Figure 40. Mexico Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Plague Therapeutics Market Share by Country (2020-2031)

Figure 44. Turkey Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Plague Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. CordenPharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 48. Cipher Pharmaceuticals Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 49. Pfizer Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 50. Bayer HealthCare Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 51. Eli Lilly Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 52. Achaogen Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 53. Aurobindo Pharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 54. GlaxoSmithKline Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 56. Aspen Pharmacare Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 57. Biocon Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 58. Astellas Pharma Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 59. Melinta Therapeutics Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 60. Basilea Pharmaceutica Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 61. Allergan Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 62. Abbott Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 63. AstraZeneca Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 64. AmpliPhi Biosciences Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 65. Actelion Pharmaceuticals Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 66. Chiesi Farmaceutici Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 67. Exoxemis Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 68. Merck Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 69. DynPort Vaccine Company LLC Revenue Growth Rate in Plague Therapeutics Business (2020-2025)

Figure 70. Bottom-up and Top-down Approaches for This Report

Figure 71. Data Triangulation

Figure 72. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Ant Killer Market Research Report 2024

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pesticide Technical Material Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Disease Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bartonellosis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Constrained Peptide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lyme Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Api Drug Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chemical API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Babesiosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Active Tuberculosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Anti tuberculosis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions